The Squash Court Startup Quietly Rolling Up America's Med-Spas

The best startup stories rarely begin in a boardroom. This one began on a squash court. Somewhere between serves at Harvard Business School, Courtney Ellenbogen and Faraz Karbasi kept circling the same idea: the medical aesthetics business was full of brilliant clinicians who were terrible at - or exhausted by - running companies. Great with a syringe, drowning in payroll software. The two classmates decided that was a business worth building around. In 2018 they launched Aesthetic Partners, and the pitch has barely changed since.

That pitch is deceptively simple: keep doing the medicine you love, and let us take the second job off your plate. Aesthetic Partners is a practice-management company for medical aesthetics, cosmetic dermatology, and plastic surgery clinics. It takes a stake in a founder-led practice, hands over growth capital, and absorbs the unglamorous machinery of running a business - marketing, HR and recruiting, technology and IT, accounting, and legal. The clinician keeps operating. Crucially, the clinician also keeps their name on the door.

01 / The ModelThe anti-roll-up roll-up

Most healthcare roll-ups follow a familiar arc. A private-equity-backed platform buys practices, retires the local name, standardizes everything, and patients quietly notice the place feels different. Aesthetic Partners is running the opposite experiment. It calls the approach a partnership, not a consolidation - and the distinction is the whole company.

The logic is grounded in something specific to this industry: in a med-spa, the asset walks out the door every night. Patients come back for a particular injector, a particular dermatologist, a particular front desk that remembers their name. Strip away the brand and the culture, and you can vaporize the very loyalty you paid for. By taking selective stakes and leaving each practice's identity intact, Aesthetic Partners is betting that retention - of founders and of patients - is the real moat.

02 / The ProductThe back office is the product

It is tempting to describe Aesthetic Partners as a financial player, but the day-to-day value it sells is operational. When a practice joins, it plugs into a shared stack: recruiting to fill hard-to-hire clinical roles, marketing to bring in patients, IT and technology to modernize the front and back of house, plus accounting and legal support that a solo founder would otherwise cobble together from a patchwork of vendors. On top of that sits the company's own training arm.

That training arm, AP Academy, is the piece outsiders tend to underestimate. Medical aesthetics has a chronic talent shortage - there are never enough well-trained injectors and clinical staff. A practice-management company that also trains clinicians is not just supporting its practices; it is quietly manufacturing the pipeline it recruits from. Add a Medical Advisory Board of practicing clinical leaders providing scientific education and device guidance, and the company's differentiation starts to look clinical rather than purely financial.

The bundle matters because of what it replaces. Run the counterfactual on a busy solo practice: the owner is negotiating with a medical-device vendor on Monday, interviewing a nurse injector on Tuesday, arguing with a marketing agency on Wednesday, and reconciling the books on Thursday - none of which is why they went to medical school. Aesthetic Partners' proposition is that a centralized team can do each of those functions better than a distracted founder juggling all of them, and cheaper than the founder hiring a full C-suite alone. Device and technology sourcing, regulatory compliance, staff recruitment, financial planning, and practice-branding all move onto one shared platform. The founder gets their evenings back; the practice gets institutional muscle it could not afford on its own.

It also opens a growth lever that most independent clinics never reach: the de novo location. Opening a second or third site is capital-intensive and operationally brutal for a first-time operator. With growth capital and a playbook for site selection, buildout, hiring, and launch, a founder inside the network can expand in a way that would be reckless alone. Expansion, in other words, is not a side benefit of the partnership - for many practices it is the entire reason to sign.

03 / The CustomersWho actually signs up

The customer here is not the patient - it is the practice owner. Aesthetic Partners targets high-end, physician-led, patient-centric clinics, and it has shown a preference for suburban markets rather than the crowded coastal metros where every consolidator is elbowing for deals. Its footprint runs across California, Florida, North Carolina, and Virginia. The founders it courts tend to be successful operators who have hit a ceiling: brilliant clinically, but out of hours in the day to also be a full-time CEO.

For those founders, the alternative to Aesthetic Partners is stark: sell outright to a consolidator and watch the brand disappear, join a branded chain and lose autonomy, or stay fully independent and keep doing two jobs. The partnership model positions itself squarely in the gap - capital and scale without the erasure.

04 / The BackersWhy Norwest wrote the check

In November 2023, the model got an institutional endorsement. Norwest Venture Partners - a multi-stage investor managing roughly $12.5 billion in capital - took a minority stake in Aesthetic Partners. General Partner Sonya Brown and Scott Mitchell joined the board of directors. The terms were not disclosed, but the intent was clear: fund infrastructure and push into new markets on top of the existing clinics.

There is a broader thesis buried in that check. Cosmetic dermatology and medical aesthetics remain one of the last big fragmented corners of consumer healthcare - thousands of small, owner-run practices, few dominant national brands, and demand that has climbed steadily with the mainstreaming of injectables and laser treatments. Consolidating that fragmentation, without triggering the brand-erosion that usually sinks roll-ups, is a genuinely hard problem. A fund like Norwest does not back a med-spa; it backs a playbook for solving that problem at scale.

Timing helps. Aesthetic Partners was one of the earliest movers in a category that has since gotten crowded, which means it built relationships and a reputation before the space filled with capital chasing the same physician-owners. That head start is not trivial in a business built on trust: a founder deciding whether to let an outside partner touch their life's work is buying the counterparty as much as the terms. Being early - and being able to point to founders who joined and stayed - is its own form of proof.

05 / The PeopleTwo in a box

Aesthetic Partners is run as a true co-CEO shop. Ellenbogen brings the finance and healthcare-investing lineage - stints spanning the Carlyle Group, Deutsche Bank's healthcare banking team, Johnson & Johnson's digital-health partnerships, and Victress Capital, plus an MBA from Harvard Business School. Karbasi brings the operating and strategy side, with a background across ZS Associates, Pharmascience, and Persistence Capital Partners, and his own Harvard MBA. It is a female- and minority-owned company - still uncommon among healthcare roll-up platforms - which the founders treat as part of the identity rather than a footnote.

06 / The TakeawayA template worth watching

Whether the partnership model outperforms the buy-and-rebrand approach will take years to prove. Roll-ups are judged on retention and margins over a full cycle, not on press releases. But the shape of the bet is interesting well beyond aesthetics. Plenty of fragmented, founder-run industries - dental, veterinary, home services - face the same tension between the efficiency of scale and the fragility of local trust. If Aesthetic Partners can grow a network without hollowing out the practices inside it, the more valuable export might not be a chain of clinics. It might be the playbook.

The risks are real and worth naming. Partnership models are harder to standardize than command-and-control chains, and letting every practice keep its own brand can mean giving up some of the cost savings that make roll-ups attractive to investors in the first place. Growth by acquisition also carries integration drag: each new founder is a new personality, a new set of systems, a new culture to fold in without breaking. Whether Aesthetic Partners can keep its promise - autonomy for founders, efficiency for the platform - as the network doubles is the open question the next few years will answer.

For now, the company is doing the unflashy work: adding practices, building shared systems, training clinicians, and keeping founders happy enough to stay. The glossy part of medical aesthetics is the before-and-after photo. The business, it turns out, is mostly spreadsheets - and Aesthetic Partners has decided the spreadsheets are the product.